Sergio Garrote, Paralympic champion, trusts in Quickie

Sergio Garrote, Paralympic champion, trusts in Quickie

Regner® Editorial Team

Aiguaviva -

16/09/2024

PORTADA sergio garrote (1)

Gold medal paralympic champion

Sergio Garrote is a Spanish Paralympic champion in the time trial and a bronze medalist in the road race at the Tokyo 2021 Paralympic Games. With his sights now set on the Paris Paralympics in 2024, Sergio is preparing to compete on the 4th and 5th of September.

Sergio, a determined and exceptionally talented athlete, faced a life-changing challenge in the early 2000s following an accident at work. The spinal cord injury he suffered left him a quadriplegic, affecting all four limbs. After spending a year in the hospital, Sergio had to relearn how to cope with his daily life.

Fourteen years after his injury, cycling entered Sergio’s life and completely transformed it.

A fortuitous encounter

Sergio’s journey into cycling began when a friend introduced him a handbike. He instantly reconnected with the sport and immediately got a second-hand QUICKIE. From that moment on, Sergio started collecting international awards, accumulating more than 90 awards to date. Sergio credits cycling, and sports in general, with positively impacting every aspect of his life. With strict discipline and a relentless drive, he views the awards and recognition he has received as the ultimate reward for his hard work, exemplified by his gold medal victory at the Tokyo 2021 Paralympics after four years of intense training.

Quickie by Sunrise Medical

QUICKIE is a division of the German company Sunrise Medical, a global leader in wheelchair and power wheelchair solutions, operating in over 130 countries. REGNER has been a trusted supplier to Sunrise Medical since its inception, providing crucial mobility solutions for athletes like Sergio Garrote.

QUICKIE offers both electric and manual wheelchairs, tailored to meet the specific mobility needs of each customer. Sergio’s first introduction to handbikes was through QUICKIE’s manual wheelchair section.

REGNER's technologies and actuators in wheelchairs

REGNER’s expertise in motion control and mobility solutions has a significant impact across various applications. Our component development and motion solutions integration are integral to QUICKIE’s design process, ensuring seamless functionality in both manual and electric wheelchairs.

REGNER’s linear actuators, specifically the RA-90 and RA-91, are expertly integrated into these wheelchairs, offering the precision, reliability, and comfort required by Sunrise Medical. Both companies prioritize high-quality standards and a commitment to their clients.

The RA-90 was specifically designed to be integrated into QUICKIE power wheelchairs, providing movement in the back and footrest systems as well as the anti-tip system. REGNER subsequently developed the RA-91, a high-performance linear actuator designed to improve power wheelchair support in the U.S. market. With a power rating of 4500 N, the RA-91 features an innovative stroke regulation system and highly advanced electronics, allowing it to quickly adapt to a variety of applications.

In addition to power wheelchairs, REGNER also provides solutions for manual wheelchairs, developing technologies and procedures that improve the comfort and performance of manual wheelchairs. As a key supplier to Sunrise Medical, and specifically to QUICKIE, we integrate various components into their manual wheelchairs, such as brakes, footrests and lighting.

Shared values

Our mission is to provide motion solutions that enhance everyday life, with a strong focus on the field of healthcare and medical aids. At REGNER, we are committed to driving innovation and design development for a wide range of devices that facilitate work, life and mobility in all types of situations.

REGNER’s commitment is rooted in innovation, particularly in cases like Sergio Garrote’s, where our systems and developments facilitate reintegration, improve mobility, and, in some instances, help achieve dreams and championship medals, as the Spaniard did.

Share this article!

Grifols’ oncology treatment robot arrives at St James Hospital

Grifols’ oncology treatment robot arrives at St James Hospital

Regner® Editorial Team

Aiguaviva -

22/08/2024

Oncology treatment robot arrives at St James's Hospital

Kiro Grifols’ automated solution for the preparation of oncology treatments in its Kiro Oncology division, already implemented in the United States, has arrived at Trinity St James’s Cancer Institute in Dublin to produce chemotherapy drugs, thus revolutionizing the normal operation of this hospital and, above all, cancer treatment.

Chemotherapy, traditionally a manual and physically intense procedure, often results in strain injuries to the professionals in the field due to the intensity of the production. These automated systems not only increase accuracy and safety, but also reduce the physical burden on medical staff.

Kiro Oncology and its automated solution

Kiro Oncology markets its automated chemotherapy drug preparation system worldwide. In the United States, this innovative device has been implemented due to the high demand for advanced technologies in the field of oncology, offering solutions that improve accuracy and safety in the preparation of treatments.

Kiro Oncology’s system handles a wide variety of vials and final containers, allowing the preparation of specific doses and small batches for each patient, using both liquid and lyophilized drugs.

This system is based on automated flow control of medications, using bar code readers and cameras to verify the identity of medications and containers, reducing the risk of human error and ensuring full traceability of each dose prepared.

The automation includes a gravimetric system that verifies the weight of the drugs at all stages of the compounding process, ensuring accurate dosing and improving patient safety.

Trinity St James' Hospital's newest addition

Trinity St James’ Cancer Institute in Dublin has become the first hospital in England and Ireland to incorporate the Kiro Grifols system for producing chemotherapy drugs. This robot starts with the production of thirteen cytotoxic chemotherapy drugs and is expected to reach 50% of drugs, greatly benefiting the pharmacist team by protecting them from common strain injuries and exposure to hazardous drugs.

The integration of this system also benefits patients, allowing them to quickly customize their doses and eliminating the human error present in manual preparation. The first patient to receive this treatment at the center has confirmed that she has noticed no difference between the traditional method and the new automated system.

Dosing systems in drug production

Automated dosing systems use linear actuators to regulate the flow of medication with high precision. These mini actuators, such as those produced by REGNER, convert the rotary motion of a motor into linear motion, allowing precise control of the displacement of components in the dosing system. The mini linear actuators adjust the valves to control the flow and allow fine adjustments of volumes, ensuring accurate dosing of medications.

The automation provided by these actuators reduces the risk of human error and improves consistency in dosage preparation. REGNER is an expert in linear actuators and microactuators that stand out for their reliability, being ideal for integration into automated control systems and dosing management software. In the healthcare field, especially in the preparation of critical treatments, the accuracy and durability of these actuators are essential to ensure the safety and efficacy of drug delivery.

Experience and commitment to innovation is what drives the company to this type of integrations, with a long history in medical devices, the design and production of mini linear actuators to regulate dosing systems becomes a natural extension of our expertise, allowing us to offer accurate and reliable solutions that improve the performance and efficiency of medical systems.

Share this article!

REGNER joins circular economy

REGNER joins circular economy

Regner® Editorial Team

Aiguaviva -

29/07/2024

PERTE concession for manufacturing industries

The current environmental crisis demands an urgent change in our production and consumption patterns. Linear economics based on the “extract-produce-use-throw away” cycle is no longer viable if we seek a sustainable future. The transition to a circular economy, which maximizes the use and useful life of resources, is imperative. This approach not only preserves the environment, but also opens up new opportunities for technological innovation and business competitiveness.

To this end, the Ministry of Industry, Trade and Tourism awarded REGNER last November a grant within the framework of the strategic plans for manufacturing industries to carry out a project focused on circular economy called: Eco-innovation in the manufacturing process of microactuators for the improvement of efficiency, sustainability and useful life.

REGNER will leverage its extensive product engineering expertise, thermoplastics knowledge and experience, data analysis, electronic engineering with component and microchip selection, mobile software design to create technology for motion control.

Its microactuator solutions are used to provide smooth and precise motion for dosing systems, ultrasonic cleaning devices, optical spectrometers, analytical equipment and systems for the pharmaceutical industry, as well as suspension systems for electric wheelchairs.

Principles of eco-innovation and circular economy

The project is based on three fundamental pillars that ensure both environmental sustainability and the efficiency and durability of the product:

Replacement of metal components with recycled thermoplastics:

  • The steel used in the screw-nut transmission system will be replaced by recycled thermoplastics, manufactured using injection molds developed by additive manufacturing. This replacement not only reduces the need for lubricants and maintenance, but also increases the energy efficiency of the micro actuator by at least 14%.
  • Similarly, the steel stem will be replaced by a recycled thermoplastic, replacing chemicals such as cyanoacrylate adhesives, resulting in a cleaner and more sustainable product.
  • Redesign and optimization of components:

    The elimination of adhesives and greases, together with the optimization of friction by means of self-lubricating plastics, will extend the service life of the micro actuator by 50%.

Additive manufacturing for the design of injection molds:

  • The implementation of 3D printed molds for the injection of parts in recycled thermoplastics will replace conventional methods. This approach allows for more agile, less polluting manufacturing and facilitates rapid iterations and optimizations in the design of components such as nuts, spindles and shanks.

Advanced electronics integration:

  • A digital solution will be developed that allows remote monitoring and updating of the microactuator. This includes the control of parameters such as consumption, position, direction and speed, thus ensuring that the product can adapt to various needs and prolong its service life.

A future with sustainable microactuators

This project not only promotes a circular economy by reducing dependence on virgin materials and minimizing waste, but also improves the company’s competitiveness by offering more durable and efficient products. REGNER’s microactuators will find applications in dosing systems, ultrasonic cleaning devices, optical spectrometers, analytical equipment, systems for the pharmaceutical industry and suspensions for electric wheelchairs.

With an established track record in product engineering and motion control technology, REGNER is well positioned to lead this transformation towards more sustainable solutions. Its focus on product design engineering and eco-innovation ensures that every step taken not only aligns with sustainability principles, but also brings added value to its customers and the market in general.

In short, the transition to a circular economy is not only an environmental necessity, but also an opportunity to redefine efficiency and competitiveness in the technology industry. REGNER’s commitment to sustainable innovation marks a promising path towards a future where technology and respect for the environment go hand in hand.

Diseño sin título (1)

Share this article!

World’s lightest sanitary elevator arrives to the market

World’s lightest sanitary elevator arrives to the market

Regner® Editorial Team

Aiguaviva -

22/04/2024

Drive Medical, manufacturer of bath, shower and WC solutions, launches the world’s lightest electric sanitary elevator, weighing less than 4 kilograms, thanks to REGNER‘s RA42 actuator technology. This medical device features a record weight compared to previous systems on the market, characterized by their bulky mechanism thanks to the integration of an actuator designed specifically for this function, which enables the raising and lowering movement and which is fully integrated inside the sanitary device for people with reduced mobility.

Drive Medical and REGNER's union

The cooperation between Drive Medical and REGNER, specialist in electric linear actuators, started in the winter of 2023, when the manufacturer of solutions for improving the lives of people with reduced mobility had a new product in mind an electronic system that would help people with reduced mobility in everyday situations at home, as well as in hygiene control.

This project was designed to address the daily needs of people who do not have full control of their mobiliy, making routine tasks such as using the toilet, showering or washing difficult. When it comes to going to the toilet, it triggers uncomfortable situations, as these people may fall down on the seat because they do not have a support at the right height, or it may be difficult for them to get back up again.

Innovation and project execution

In the last few months, aware of this problem, Drive Medical’s engineers, together with the team from REGNER have worked hard to conceive a light electronical device, smartly designed that would solve the problem of the current market, and would also be integrated to the seat, with which provided with movement, the action of accommodating and incorporating into the toilet is made possible.

Once the focus was pointed on solving these charactersitics, they designed an ultralight electrical device, reduced in size compared to its predecessors. Its smart design is integrated in the seat, and with the given movement, it allows the easy and effective accommodation and incorporation.

For Marc Sarquella, senior R&D engineer at REGNER, this new development is a milestone:

  • Thanks to RA42 actuators contained in this system, an up and down movement is produced, which follows the actual movement of the user when getting in and out the seat, prventing people with reduced mobility from dropping into the seat, and helping them and giving them a safe support when incorporating and standing up, thus avoiding adverse movements. There’s no such system in the market“.

RA42

The RA42, REGNER’s latest addition to its product porfolio, is the linear actuator responsible of providint this clean and safe motion offered by the medical aid, integrated elegantly into the device, the actuators cause the lifting and lowering motion as soon as it is remotely activated.

The company’s engineers took into account in detail the characteristics required by the application so that the users would not suffer any adverse movement and this system would guarantee their safety and well-being, stating that there is no other system of this type on the market that is capable of performing the same function.

The RA42 linear actuator marks the beginning of a new era of lightweight electric systems, as it weighs less than 4 kg, making it easy to handle.

Perfect combination of design and comfort

Drive Medical’s engineers wanted a solution that could be easily integratedinto the toilet, that could blend in with the toilet, so that people with this type of difficulty could maintain their autonomy in a safe and comfortable way

As is well known, there are different solutions on the market, but they all fall short of the needs of users, and are considered not very advanced, even deficient in terms of mechanism, weigh and the aggravating factor that they take up a lot of space.

The result of the work of the engineers of both companies is an electric toilet elevator with a perfect balance between weight, design and usability that offers the feeling of being fully integrated into the toilet and is suitable for any type of WC. Moreover, the battery is invisibly installed inside the device. Its control system guarantees smooth and reliable movements.

Drive Medical, manufacturer of advanced home medical devices

For over 20 years , Drive Medical has been synonymous with high technology. Its mission is to lead the world with innovation and healthcare solutions that improve people’s lives. At REGNER, we are proud to work alongside with this company’s engineers, with the goal of contributing to these type of systems innovation ., where motion control has a very promising place in terms of improving and designing new products that are more in line with people’s current situation.

The medical device market is experiencing a very significant increase in investment and innovation in recent years. At REGNER we are focused in research and development of these devices, applying our know how in motion control.

Share this article!

Technological innovations in medical devices: actuators in rehabilitation systems

Technological innovations in medical devices: actuators in rehabilitation systems

Regner® Editorial Team

Aiguaviva -

21/02/2024

HOH BONA

In the world of medical technology, advances are redefining healthcare and improving patients’ quality of life.

Two crucial areas in this field are control systems and actuators, essential elements in the production of medical devices such as prostheses and diagnostic equipment.

In this article, we will explore how these technological innovations are transforming the way we address medical challenges.

Prosthetics: moving towards personalized mobility

Modern prostheses are not simply mechanical replacements, but technological extensions that integrate intelligently with the human body. Electric actuators play a crucial role in providing precise and controlled movements These actuators are connected to control systems, which act as the bridge between the prothesis and the user.

Control systems are capable of interpreting the user’s signals, captured by sensors such as electromyograms (EMG), to translate them into specific movements of the prosthesis. This level of customization allows users to modulate the strength, speed and position of the prosthesis, adapting it to different daily tasks and activities. Thus, technology not only restores functions, but also enhances the autonomy and quality of life of those who use it.

Diagnostic Equipment: Accuracy and Efficiency in Medical Diagnostics

Devices such as the Hand of Hope (HOH) stand out for their innovative approach, focused on leveraging technological advances to create not just a rehabilitation tool but a comprehensive solution incorporating devices such as linear actuators

An outstanding feature that drives the efficiency of the HOH is the presence of REGNER linear actuators They play a crucial role in facilitating precise movements tailored to the individual needs of the patients.

The hand is placed on the back of the damaged hand, with two surface sensors attached to the extensor and flexor muscles of the arm, to detect surface electromyographic (EMG) signals for active participation during exercise.

The EMG signals are processed so that the patient can see the movement of the muscle, where the EMG electrodes are positioned, it should be noted that there is no electrical current applied to the patient.

The HOH therapy device is intended for use in patients who need hand or forearm rehabilitationmaking it easier for them to begin to contract the muscle voluntarily, to have motor control and coordination, it also helps them with muscle relaxation, to have motivation to improve, control of abnormal muscle activity and have continuous reinforcement of correct responses

Future prospects and continuous innovation

As medical technology advances, the integration of linear actuators into devices such as the Hand of Hope continues to evolve, the ability of these actuators to provide controlled movements tailored to the specific needs of patients underscores the importance of customization in the rehabilitation process.

In this case, REGNER contributed his expertise in control systems, integrating his RA-MINI ALU, a perfect combination between power and ultra compact design. The RA-MINI ALU is perfect for those applications, such as HOH, where tilt, lift, retract and thrust forces are required, in a very limited space.

The customization fo our control systems is very important to us, considering that technological innovation is a priority in REGNER, where we listen and understand the projects of each client, motivating us to innovate and contribute to the development of technological advances.

Share this article!

REGNER 2023 RECAP

REGNER 2023 RECAP

Regner® Editorial Team

Aiguaviva -

05/01/2024

recap2023

In the 2023 REGNER RECAP, we would like to share our best moments with you, ranging from product launches, receiving commemorations, finishing projects and starting new ones. Likewise, having closed 2023, we consider that we have had a very good year, let’s start with a summary of our highlights of each month, where REGNER has innovated, improved and grown.


¡Hopefully 2024 will be even better!

JANUARY

We started the year expanding our facilities, our characteristic warehouse in Aiguaviva, Girona, now has a new partner, as we have acquired the continuous one and we have started its remodeling. With about 2000 m², this hall will be part of REGNER's production and execution process.

FEBRUARY

This month we supported one of our major commitments, the decarbonization plan, by providing electronic solutions for the electric bicycle sector.

MARCH

In March we started manufacturing a new generation of actuators, specifically for laboratory machinery , these were integrated for the function: ultrasonic cleaning.

APRIL

This month was marked by
the development of a linear actuator for electric motorcycles with IP67 protection.

MAY

Continuing with the development of new linear actuators, adapted to the needs of our customers,
this month we launched a complete new line of micro-actuators for real-time water analysis.

JULY

This month we started the development of a Cloud platform for medical data.

AUGUST

Then in August we began to develop an innovative project to implement technical aids equipment with motion control systems.

SEPTEMBER

This September REGNER opened its doors to social networks, with the entry of Emma to the company, showing a little more of our day to day.

OCTOBER

We received support from the Government of Spain with the granting of a PERTE Industrias Manufactureras to implement decarbonization plans in our company.

NOVEMBER

This past month, we received confirmation that we were awarded a new R&D project. REGNER will develop an innovative medical device as part of an international research program.

You may be interested in:

Sergio Garrote is a Spanish Paralympic champion in the time trial and a bronze medalist in the road race at the Tokyo 2021 Paralympic
Kiro Grifols’ automated solution for the preparation of oncology treatments arrives at Trinity St James’s Cancer Institute…
German company AKTORmed has revolutionized the way surgeons work with endoscopes with its Soloassist II robotic arm.

Automation: the power force in biomedical research

Automation: the power force in biomedical research

Regner® Editorial Team

Aiguaviva -

20/11/2023

pexels-pavel-danilyuk-8438951

Automation in biomedical investigation; promoting research instead of wasting valuable time. Biomedical investigation is a nonstop growing field, driven by the research for disease solutions. The improvement of treatments and the deeper comprehension of the human body. In this discovery process, automation performs a crucial part, as it helps medical investigation laboratories accelerate their experiments and progress in the reach for quality solutions. 

 

 

Automation and motion control are key tools that have turned to be essential.

Automation: the power force in biomedical research

Referring to the implementation of robotic systems, controllers and actuators carry out repetitive but precise tasks, that are essential in the laboratory. This allows concentration in most valuable tasks, such as experimental design and result interpretation, while boring and repetitive activities are done by machines. Let’s highlight some of the most important aspects of automation in biomedical investigation.

 

Sample preparation and processing are such difficult steps in research. Pipetting automation, centrifugation and microliter plate handling, for example, allow high throughput testing to be performed consistently and accurately.  

 

In high performance tests, automation is essential, as it includes the evaluation of thousands of compounds looking for biologic activity, being extremely useful to discover new medicines or therapies.

Biomedical investigation often requires conducting experiments in specific temperature and humidity conditions. So to carry them out they use automation systems that can regulate and control these conditions constantly, reducing the variability in results. 

 

In data analysis, automation doesn’t just involve experiments execution, it also includes data analysis. Software automated algorithms can process a huge data set efficiently, identifying patrons and tendencies which could easily be ignored in manual analysis.

Tailored motion control solutions for biomedical research

Motion control systems are used to guide and coordinate robot operation, robotic arms, pipetting devices and other equipment. Some of the top applications are:

 

Sample manipulation, where robotic arms with precise actuators are used to handle samples, which guarantees that they are placed accurately in the desired locations in the Petri dish, microliter plate or others.

pexels-pixabay-256262

We also have high resolution microscopy; here, motion control systems allow the precise movement of microscopes, which is crucial for providing detailed images in cellular and tissue studies. 

 

In liquid transfer, we need the precision of motion control systems to reduce the cross contamination, improving accuracy in experiments.

 

We also include compound screening, when we look for new medicines, motion control systems guide screening platforms that allow the fast evaluation of thousands of compounds, looking for biological activity.

Going forward in medical science

Motion control and automation have changed the functioning of research in the biomedical field, accelerating the velocity in which experiments are done, and improving the reproducibility of the results. This means significant improvements in the understanding of diseases, therapies development and the identification of new medicines. 

Share this article!

PAL ROBOTICS and REGNER collaborate on R&D for agricultural robotics

PAL ROBOTICS and REGNER collaborate on R&D for agricultural robotics

Regner® Editorial Team

Aiguaviva -

08/11/2023

foto blog

This summer 2023Pal Robotics used the actuatorsREGNER RA-MINI ALU o integrate them into automated guided vehicles (AGVs), but in this case, we’re not talking about just any vehicle.

Pal Robotics is part of the European projectCANOPIES a collaborative paradigm for human workers This project is the first attempt to introduce a collaborative prototype in precision agriculture for permanent crops.

The main objectives of the project, together with the European Union, were the following: to develop new human-robot interactions (HRI), foster new collaborations between both parties (HRC) and establish methodologies for the coordination of multiple robots (MRC). These objectives were aimed at implementing an efficient paradigm of collaboration between human workers and teams of multiple robots. This approach was validated in the context of table grape vineyards.

The intention is for the robot to be able to perform a series of tasks that a human worker is used to doing, such as identifying whether the bunch is at the right point to be picked, detecting which branches of the vineyard need to be pruned and how to do it without damaging the vineyard or the grapes. One point that the tasks have in common is that they require precision, so the robot has to be equipped with different systems and therefore advanced design, and this is where REGNER entra to help.

Canopies is part of the H2020 plan, and has a four-year duration and a budget of 6.9 million euros. The project is a great opportunity to take the world of agriculture to a more sustainable level, and can offer many new opportunities, as well as solutions that would revolutionize a sector with an enormous history and tradition. It should also be noted that productivity would increase considerably, and we would move to a more efficient type of harvesting.

RA-MINI series actuators, provided by REGNERwere used to give mobility to a robotic gripper, they were placed at the top of the same providing linear movement. The actuators, in this case, are limit switcheswhich means that it cuts off the power supply when it detects that it has reached the end of its travel. Because of the possibilities offered by this movement, Pal Robotics has incorporated a tool at the end of it that allows the manipulation of the grape bunch in the vineyard field, the branches, as well as other functions that can be commanded to the prototype.

This type of small actuators, presented as RA-MINI in REGNER, mentioned before, stand out due to its small size, which allows them to be introduced or placed in difficult locations or where there is very little space, as in this case the robot’s hand, or usually touching other sectors, such as the medical, we could find them in instruments for the analysis and for diagnostic, laptops, mass spectrometry, medical devices and even in our home. This is part of motion control, which is the automation of different devices.

La consultoría de marketing digital se ha llevado a cabo con el apoyo del programa International eTrade de Acció. This coupon is intended to facilitate the internationalization of companies through digital channels. To this end, companies have access to an analysis of their online presence, a definition of the international digital strategy (selection and definition of markets, audiences, objectives and channels, among others) and an action plan for digital channels.

Supported by:

Share this article!

The importance of EMC certifications: lessons from iPhone12 recall

The importance of EMC certifications: lessons from iPhone12 recall

Regner® Editorial Team

Aiguaviva -

20/09/2023

20190326_080844

Automation in biomedical investigation; promoting research instead of wasting valuable time.

Biomedical investigation is a nonstop growing field, driven by the research for disease solutions. The improvement of treatments and the deeper comprehension of the human body. In this discovery process, automation performs a crucial part, as it helps medical investigation laboratories accelerate their experiments and progress in the reach for quality solutions.

Automation and motion control are key tools that have turned to be essential.

Automation: the power force in biomedical research.

Referring to the implementation of robotic systems, controllers and actuators to carry out repetitive but precise tasks, that are essential in the laboratory. This allows concentration in most valuable tasks, such as experimental design and result interpretation, while boring and repetitive activities are done by machines. Let’s highlight some of the most important aspects of automation in biomedical investigation.

 

Sample preparation and processing are such difficult steps in research. Pipetting automation, centrifugation and microliter plate handling, for example, allow high throughput testing to be performed consistently and accurately.  

 

In high performance tests, automation is essential, as it includes the evaluation of thousands of compounds looking for biologic activity, being extremely useful to discover new medicines or therapies.

 

Biomedical investigation often requires conducting experiments in specific temperature and humidity conditions. So to carry them out they use automation systems that can regulate and control these conditions constantly, reducing the variability in results. 

 

In data analysis, automation doesn’t just involve experiments execution, it also includes data analysis. Software automated algorithms can process a huge data set efficiently, identifying patrons and tendencies which could easily be ignored in manual analysis.

Motion control in biomedical research

Motion control systems are used to guide and coordinate robot operation, robotic arms, pipetting devices and other equipment. Some of the top applications are

Sample manipulation, where robotic arms with precise actuators are used to handle samples, which guarantees that they are placed accurately in the desired locations in the Petri dish, microliter plate or others.

pexels-pixabay-256262

We also have high resolution microscopy; here, motion control systems allow the precise movement of microscopes, which is crucial for providing detailed images in cellular and tissue studies.

In liquid transfer, we need the precision of motion control systems to reduce the cross contamination, improving accuracy in experiments.

We also include compound screening, when we look for new medicines, motion control systems guide screening platforms that allow the fast evaluation of thousands of compounds, looking for biological activity.

Going forward in medical science

Motion control and automation have changed the functioning of research in the biomedical field, accelerating the velocity in which experiments are done, and improving the reproducibility of the results. This means significant improvements in the understanding of diseases, therapies development and the identification of new medicines.

Share this article!

REGNER® boosts the growth of Girona region with increased exports

REGNER® boosts the growth of Girona region with increased exports

Regner® Editorial Team

Aiguaviva -

31/10/2022

magatzem

REGNER® has intensified its growth during the first two quarters of this year 2022, increasing exports of its solutions by more than 12%. In this way, the Aiguaviva-based company also boosts the positive economic recovery figures for the province of Girona 

 

 

Exports from Girona have grown progressively during this period, achieving a cumulative increase of 15% and with variations of up to 27%, such as the one recorded last August, when they exceeded 5,000 million euros in the cumulative 2022 course compared to the 450.18 million euros exported in 2021.

According to Ministry of Economy statistics, the main sectors responsible for this growth are agri-food, chemicals and machinery and technology manufacturers, in which REGNER® is located. This segment has increased from 32.37 million euros in exports in August 2021 to 43.18, a remarkable increase of 33.40%.

For its part, after the end of the second quarter of 2022, the REGNER® export figure increased by 12.3% compared to the same period in 2021.

 

England, China and Europe, in general, have been the main markets where the company has increased the presence of its products, positioning itself as a reference brand in the motion control sector.

To consolidate this steady growth, the company has developed new marketing and communication strategies aimed specifically at these international markets.

 

The company’s main line of action is based on deploying a digital internationalization plan that will allow the company’s solutions to have a greater and better visualization abroad, either with its range of customized products (OEM) as well as with the brand’s standard solutions, available in the online store. For this challenge, REGNER® has relied on the support of renowned consulting firms in the area, drawing the strategic lines of action for the coming years.

 

The digital marketing consultancy has been carried out with the support of Acció‘s International eTrade program. This coupon is intended to facilitate the internationalization of companies through digital channels. To this end, companies have access to an analysis of their online presence, a definition of the international digital strategy (selection and definition of markets, audiences, objectives and channels, among others) and an action plan for digital channels.

Supported by:

Share this article!